Keshav K. Singh
Dr. Singh is Professor of Oncology at Roswell Park Cancer Institute, the first cancer research, treatment and education center established in the United States. Prior to joining Roswell Park Cancer Institute, he was an Assistant Professor of Oncology and Environmental Health at Johns Hopkins School of Medicine. He is an expert in mitochondrial genetics and it role in tumorigenesis. Dr. Singh is the author of more than 65 research publications, including three books entitled Mitochondrial DNA Mutations in Aging, Disease and Cancer, Oxidative Stress, Disease and Cancer and Mitochondria and Cancer. Dr Singh founded the Mitochondria Research Society, is the founding editor-in-chief of the journal Mitochondrion and is instrumental in promoting Mitochondrial Research and Medicine around the world. He is an international advisor to the Asian Society for Mitochondria Research and Medicine, Korea and Mitochondrial Physiology Society, Austria. Dr. Singh was awarded an Individual National Research Service Award from National Cancer Institute, a FIRST Award from National Institute of Environmental Health, National Institute of Health, and a Scientist Development Award from American Heart Association. Dr. Singh serves or has served on the editorial boards of Cancer Biology & Therapy, Technology in Cancer Research and Treatment, Nanomedicine, FEMS Yeast Research and Molecular Cancer. He serves as an expert peer reviewer for several other journals. He is also served or serves as an expert reviewer of grants submitted to U.S. Department of State, United Mitochondrial Disease Foundation, National Research Council, Canada, Komen Breast Cancer Foundation, and National Institutes of Health and other funding agencies. Dr Singh has been quoted in articles on the New Scientist, on the web, (BioMedNet), newspapers, and has given interviews to radio shows and to Associated Press on Mitochondria stories of public interest.
Biography Updated on 21 October 2010